Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

2.45
Delayed Data
As of Apr 25
 -0.0329 / -1.32%
Today’s Change
1.83
Today|||52-Week Range
12.39
+19.61%
Year-to-Date
3 Different Companies, 3 Different Approaches to Tumors
Apr 24 / GuruFocus News - Paid Partner Content
3 Different Companies With 3 Different Approaches to Tumors
Apr 24 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close2.49
Today’s open2.48
Day’s range2.45 - 2.51
Volume24,987
Average volume (3 months)128,644
Market cap$8.6M
Dividend yield--
Data as of 3:57pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)-31.50%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
BASIBioanalytical System...0.000.00%
YTENYield10 Bioscience I...0.000.00%
ABACAoxin Tianli Group I...+0.11+6.21%
FSIFlexible Solutions I...-0.04-2.20%
Data as of 3:59pm ET, 04/25/2017

Financials

Last reporting dateMarch 9, 2017
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$0.00
Annual profit (last year)-$22.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts


Search for Jobs